Search for: "State v. Price" Results 3261 - 3280 of 13,235
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Mar 2019, 7:59 am by Eric Goldman
Citing Thompson v. 1800-Contacts, the court finds antitrust standing among consumers who possibly paid higher prices due to the restrictions on keyword ads: Plaintiff has alleged that Defendants agreed to manipulate paid search results so that when a cons [read post]
28 Mar 2019, 12:45 pm by Parr Richey Frandsen Patterson Kruse LLP
From November 2004 to January 2011, the actual price Door Shop should have paid ACE for electric service was $36,081.86. [read post]
28 Mar 2019, 8:56 am by Ronald Collins
The following is a series of questions posed by Ronald Collins to Stephen Budiansky concerning Budiansky’s book “Oliver Wendell Holmes: A Life in War, Law, and Ideas” (W.W. [read post]
27 Mar 2019, 11:19 am by John Elwood
§ 2000e-2(a)(1), meant “gender identity” and included “transgender status” when Congress enacted Title VII in 1964; and (2) whether Price Waterhouse v. [read post]
27 Mar 2019, 1:00 am by Thaddeus Mason Pope, JD, PhD
Pharmaceutical Pricing Jaime King, University of California Hastings College of the Law, The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs Marc Rodwin, Suffolk University Law School, Controlling Pharmaceutical Prices: What the U.S. [read post]
26 Mar 2019, 1:05 pm by Patricia Hughes
The question is, are there times we should say that the rule of law is too high a price to pay to achieve some other goal? [read post]
26 Mar 2019, 8:38 am by FHH Law
Information subject to ARMIS reporting also may vary depending on whether a carrier is a mid-size or large ILEC or a mandatory price-cap, elective price-cap, or non-price-cap ILEC. [read post]
20 Mar 2019, 8:43 am by John Elwood
§ 2000e-2(a)(1), meant “gender identity” and included “transgender status” when Congress enacted Title VII in 1964; and (2) whether Price Waterhouse v. [read post]
15 Mar 2019, 9:00 am by Staff
Subsequent to the FDA approval of Epidiolox, The Drug Enforcement Administration (DEA) issued a Final Order placing “FDA-approved drugs that contain CBD derived from cannabis and no more than 0.1 percent tetrahydrocannabinols” [such as Epidiolox] in Schedule V of the Controlled Substances Act,”  “Schedule V drugs are considered to have the lowest potential for abuse compared to other scheduled drugs and a low potential for psychological or physical… [read post]